Nonalcoholic Fatty Liver Disease and the Kidney: A Review

Nonalcoholic fatty liver disease (NAFLD) is associated with several extrahepatic manifestations such as cardiovascular disease and sleep apnea. Furthermore, NAFLD is reported to be associated with an increased risk of incident chronic kidney disease (CKD). Inflammation and oxidative stress are sugge...

全面介绍

书目详细资料
Main Authors: Ilaria Umbro, Francesco Baratta, Francesco Angelico, Maria Del Ben
格式: 文件
语言:English
出版: MDPI AG 2021-10-01
丛编:Biomedicines
主题:
在线阅读:https://www.mdpi.com/2227-9059/9/10/1370
_version_ 1827680039034945536
author Ilaria Umbro
Francesco Baratta
Francesco Angelico
Maria Del Ben
author_facet Ilaria Umbro
Francesco Baratta
Francesco Angelico
Maria Del Ben
author_sort Ilaria Umbro
collection DOAJ
description Nonalcoholic fatty liver disease (NAFLD) is associated with several extrahepatic manifestations such as cardiovascular disease and sleep apnea. Furthermore, NAFLD is reported to be associated with an increased risk of incident chronic kidney disease (CKD). Inflammation and oxidative stress are suggested to be the key factors involved in the inflammatory mechanisms and pathways linking NAFLD to CKD and are responsible for both the pathogenesis and the progression of CKD in NAFLD patients. This review aims to provide a more comprehensive overview of the association between CKD and NAFLD, also considering the effect of increasing severity of NAFLD. A PubMed search was conducted using the terms “non-alcoholic fatty liver disease AND kidney”. In total, 537 articles were retrieved in the last five years and 12 articles were included in the qualitative analysis. Our results showed that CKD developed more frequently in NAFLD patients compared to those without NAFLD. This association persisted after adjustment for traditional risk factors and according to the severity of NAFLD. Therefore, patients with NAFLD should be considered at high risk of CKD. Intensive multidisciplinary surveillance over time is needed, where hepatologists and nephrologists must act together for better and earlier treatment of NAFLD patients.
first_indexed 2024-03-10T06:42:26Z
format Article
id doaj.art-69c81efb292c49b4b56eb58f9324df97
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T06:42:26Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-69c81efb292c49b4b56eb58f9324df972023-11-22T17:30:49ZengMDPI AGBiomedicines2227-90592021-10-01910137010.3390/biomedicines9101370Nonalcoholic Fatty Liver Disease and the Kidney: A ReviewIlaria Umbro0Francesco Baratta1Francesco Angelico2Maria Del Ben3Geramed Dialysis Center, Fiano Romano, 00065 Rome, ItalyDepartment of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, 00161 Rome, ItalyDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00161 Rome, ItalyDepartment of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, 00161 Rome, ItalyNonalcoholic fatty liver disease (NAFLD) is associated with several extrahepatic manifestations such as cardiovascular disease and sleep apnea. Furthermore, NAFLD is reported to be associated with an increased risk of incident chronic kidney disease (CKD). Inflammation and oxidative stress are suggested to be the key factors involved in the inflammatory mechanisms and pathways linking NAFLD to CKD and are responsible for both the pathogenesis and the progression of CKD in NAFLD patients. This review aims to provide a more comprehensive overview of the association between CKD and NAFLD, also considering the effect of increasing severity of NAFLD. A PubMed search was conducted using the terms “non-alcoholic fatty liver disease AND kidney”. In total, 537 articles were retrieved in the last five years and 12 articles were included in the qualitative analysis. Our results showed that CKD developed more frequently in NAFLD patients compared to those without NAFLD. This association persisted after adjustment for traditional risk factors and according to the severity of NAFLD. Therefore, patients with NAFLD should be considered at high risk of CKD. Intensive multidisciplinary surveillance over time is needed, where hepatologists and nephrologists must act together for better and earlier treatment of NAFLD patients.https://www.mdpi.com/2227-9059/9/10/1370nonalcoholic fatty liver diseaseliver fibrosischronic kidney diseaserenal functionkidney
spellingShingle Ilaria Umbro
Francesco Baratta
Francesco Angelico
Maria Del Ben
Nonalcoholic Fatty Liver Disease and the Kidney: A Review
Biomedicines
nonalcoholic fatty liver disease
liver fibrosis
chronic kidney disease
renal function
kidney
title Nonalcoholic Fatty Liver Disease and the Kidney: A Review
title_full Nonalcoholic Fatty Liver Disease and the Kidney: A Review
title_fullStr Nonalcoholic Fatty Liver Disease and the Kidney: A Review
title_full_unstemmed Nonalcoholic Fatty Liver Disease and the Kidney: A Review
title_short Nonalcoholic Fatty Liver Disease and the Kidney: A Review
title_sort nonalcoholic fatty liver disease and the kidney a review
topic nonalcoholic fatty liver disease
liver fibrosis
chronic kidney disease
renal function
kidney
url https://www.mdpi.com/2227-9059/9/10/1370
work_keys_str_mv AT ilariaumbro nonalcoholicfattyliverdiseaseandthekidneyareview
AT francescobaratta nonalcoholicfattyliverdiseaseandthekidneyareview
AT francescoangelico nonalcoholicfattyliverdiseaseandthekidneyareview
AT mariadelben nonalcoholicfattyliverdiseaseandthekidneyareview